Is the best way to beat type 1 diabetes to simply stop it before it starts? That’s a question being tackled in new clini…
Diabetes Vaccine
Diamyd-Licensed Technology Cures Type 1 Diabetes in Mice
Researchers at UCLA have confirmed earlier findings that combinations of GABA and Antigen Based Therapy (ABT) works syne…
Lawrence Steinman’s ‘Reverse Vaccine’ Targets Immune Response in Type 1 Diabetes
Sometimes, when you’re stuck and spinning your wheels without making much forward progress, putting it in reverse can ge…
Diamyd to Launch New Clinical Study of Diabetes Vaccine in Children
Diamyd Medical is planning to launch a new clinical study with its diabetes vaccine, Diamyd, during February 2013.
The …
Experimental Drug May Protect From Type 1 Diabetes
JDRF-funded researchers at Harvard School of Public Health have found that an experimental drug, called TUDCA, can drama…
DiaPep277 Granted Orphan Drug Designation by FDA
The U.S. FDA has granted Orphan Drug designation for DiaPep277 for the treatment of type 1 diabetes (T1D) patients with …
Diapep277: Slowing the Progression of Type 1 Diabetes
Diapep277 was discovered in 1990 by Professor Irun Cohen and his team at the Weizmann Institute's Department of Immunol…
Positive Results for DiaPep277 Type 1 Diabetes Treatment in Phase 3 Study
Andromeda Biotech has announced positive initial results from a pivotal phase III clinical study of type 1 diabetes trea…
Diamyd Shifts Away from Diabetes To Cut Costs
Diamyd Medical announced it has shifted its focus from the development of the diabetes therapy Diamyd® to the the develo…
Diamyd Terminates US Phase III Study, DiaPrevent
Diamyd Medical has suspended dosing in its US Phase III study, DiaPrevent, with the antigen-based therapy Diamyd® follow…
